The growing emphasis on sustainable sourcing and premium ingredient formulations is driving global demand for squalene across the cosmetics, pharmaceuticals, and nutraceuticals sectors.
The Global Squalene Market is growing steadily, driven by increased use in skincare and dermatology, ongoing pharmaceutical needs, and a shift away from animal-derived ingredients to plant-based and bio-synthetic options. Although squalene was traditionally mainly obtained from shark liver oil, regulatory changes, sustainability goals, and ESG strategies by brands have shifted sourcing practices. Consequently, demand is now more focused on plant-derived and fermentation-produced squalene, setting the stage for sustained, long-term growth rather than short-term fluctuations.
The Global Squalene Market was valued at USD 420 million in 2025 and is expected to grow to about USD 754 million by 2033, with a CAGR of 7.6%. Growth is driven by the premiumization of cosmetic products, increased demand for high-purity bioactive ingredients in pharmaceuticals, and better scalability of bio-synthetic production methods. However, growth remains focused, with higher value in specific applications and grades rather than widespread volume increases.
Cosmetics and personal care products dominate the global market.
Cosmetics and personal care dominate the Global Squalene Market, holding the largest revenue share. Squalene’s compatibility with human skin, oxidative stability, and moisturizing qualities make it essential in high-end skincare, anti-aging products, and dermatological formulations. Its frequent use, higher inclusion rates in formulations, and capacity to justify premium pricing drive its market leadership. Conversely, pharmaceutical uses, though smaller in volume, achieve higher per-unit value due to strict purity standards and regulatory demands.
Bio-synthetic squalene emerges as a high-growth source segment.
Bio-synthetic and fermentation-derived squalene is among the fastest-growing sectors globally. This expansion is fueled by demand for reliable, high-quality sources, traceability, and reduced reliance on agricultural or marine resources. More cosmetic and pharmaceutical firms are turning to bio-synthetic squalene to achieve sustainability goals and secure a stable, long-term supply. Although plant-based squalene still accounts for most current production, biosynthetic options are becoming more popular due to their scalability and regulatory benefits.
Asia Pacific leads global demand, while Europe and North America retain high-value consumption.
Asia Pacific dominates the Global Squalene Market, driven by extensive cosmetic manufacturing, high demand for formulations, and a robust ingredient supply network. Countries like Japan, China, and South Korea play key roles in regional consumption driven by both local needs and export activities. Although Europe's and North America's markets are smaller in volume, they are high-value segments influenced by strict regulations, rising interest in plant-based and biosynthetic ingredients, and demand for luxury skincare and pharmaceuticals. Meanwhile, emerging regions are gradually adopting these ingredients as their local cosmetic and nutraceutical sectors grow.
Demand stability favors high-purity and formulation-critical applications.
Demand for stability in the global squalene market varies by application and grade. Cosmetic and pharmaceutical-grade squalene tends to be more stable because it is an essential ingredient in formulations and is less prone to substitution. Conversely, lower-grade and industrial applications are more vulnerable to price fluctuations and sourcing challenges. These market dynamics influence supplier investment strategies, leading to a greater emphasis on advanced purification methods, fermentation technologies, and securing long-term customer agreements.
Long-term demand outlook remains favorable despite sourcing and pricing challenges.
Despite ongoing issues with feedstock availability and rising costs, long-term demand for squalene remains robust. Factors such as increased regulatory oversight, a shift towards sustainable sourcing, and ongoing innovations in biosynthetic production are expected to foster continued market growth. As the market develops, expansion will likely be fueled by greater adoption of premium products, repeat purchases by major buyers, and deeper integration into cosmetic and pharmaceutical product lines.
Competitive Landscape
Major players in the Global Squalene Market include Sophim, Amyris, Kuraray, Nippon Fine Chemical, Croda International, Maruha Nichiro, and Tsuno Group. The competition features a combination of sustainability-focused sourcing methods, technology-based differentiation, and long-term supply collaborations with cosmetic and pharmaceutical formulators. The market is still somewhat fragmented, with innovation, purity standards, and supply reliability becoming increasingly critical competitive factors.